United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market (2025-2031) | Industry, Analysis, Competitive Landscape, Segmentation, Value, Growth, Size & Revenue, Companies, Share, Trends, Outlook, Forecast

Name: United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market (2025-2031) | Industry & Analysis
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Component (Equipment & Accessories, Consumables, Others), By Analytical Method (Sterility Testing, Purity Testing, Potency Testing, Identity Testing, Others), By Process (Upstream Processes, Downstream Processes, Process Development), By End-user (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations) And Competitive Landscape

Product Code: ETC9962068	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Outlook
Market Size of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2024
Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Revenues & Volume for the Period 2021- 2031
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trend Evolution
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Drivers and Challenges
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Price Trends
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Porter's Five Forces
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Industry Life Cycle
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Component for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Equipment & Accessories for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Consumables for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Analytical Method for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Sterility Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Purity Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Potency Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Identity Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Process for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Upstream Processes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Downstream Processes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Process Development for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By End-user for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Pharmaceutical & Biotechnology Companies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume By Contract Manufacturing Organizations for the Period 2021- 2031
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Import Export Trade Statistics
Market Opportunity Assessment By Component
Market Opportunity Assessment By Analytical Method
Market Opportunity Assessment By Process
Market Opportunity Assessment By End-user
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Top Companies Market Share
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Competitive Benchmarking By Technical and Operational Parameters
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Company Profiles
United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Industry Life Cycle

3.4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Porter's Five Forces

3.5 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Component, 2021 & 2031F

3.6 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Analytical Method, 2021 & 2031F

3.7 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Process, 2021 & 2031F

3.8 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in research and development within the cell and gene therapy sector

4.2.2 Growing demand for personalized medicine and innovative treatment options

4.2.3 Favorable regulatory environment supporting the development and manufacturing of cell and gene therapies

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy manufacturing and quality control processes

4.3.2 Limited scalability and production challenges in manufacturing cell and gene therapies

4.3.3 Stringent regulatory requirements and quality standards leading to compliance challenges

5 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trends

6 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Types

6.1 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Component

6.1.1 Overview and Analysis

6.1.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Component, 2021- 2031F

6.1.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Equipment & Accessories, 2021- 2031F

6.1.4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Consumables, 2021- 2031F

6.1.5 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method

6.2.1 Overview and Analysis

6.2.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Sterility Testing, 2021- 2031F

6.2.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Purity Testing, 2021- 2031F

6.2.4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Potency Testing, 2021- 2031F

6.2.5 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Identity Testing, 2021- 2031F

6.2.6 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Process

6.3.1 Overview and Analysis

6.3.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Upstream Processes, 2021- 2031F

6.3.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Downstream Processes, 2021- 2031F

6.3.4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Process Development, 2021- 2031F

6.4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By End-user

6.4.1 Overview and Analysis

6.4.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F

6.4.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F

7 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Import-Export Trade Statistics

7.1 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Export to Major Countries

7.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Imports from Major Countries

8 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Key Performance Indicators

8.1 Percentage increase in the number of clinical trials utilizing cell and gene therapies

8.2 Number of new partnerships or collaborations formed within the cell and gene therapy manufacturing quality control sector

8.3 Percentage growth in the adoption of advanced quality control technologies and methodologies

8.4 Reduction in product rejection rates due to quality control improvements

8.5 Increase in the number of regulatory approvals for cell and gene therapy products with stringent quality control measures

9 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Opportunity Assessment

9.1 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Component, 2021 & 2031F

9.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Analytical Method, 2021 & 2031F

9.3 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Process, 2021 & 2031F

9.4 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Competitive Landscape

10.1 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenue Share, By Companies, 2024

10.2 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Estonia Cell and Gene Therapy Manufacturing Quality Control (QC) Market

Ethiopia Cell and Gene Therapy Manufacturing Quality Control (QC) Market

Fiji Cell and Gene Therapy Manufacturing Quality Control (QC) Market

Finland Cell and Gene Therapy Manufacturing Quality Control (QC) Market

Gabon Cell and Gene Therapy Manufacturing Quality Control (QC) Market

Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here